STAAR Surgical

STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye. The Company provides Visian implantable collamer lenses (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers minimally invasive intraocular lenses (IOLs), including foldable IOLs for use in minimally invasive cataract surgical procedures; aspheric IOLs that produce a clearer image than traditional spherical lenses; and nanoFLEX IOL, a single piece collamer aspheric optic, as well as preloaded injectors for use in cataract surgery.
Company Growth (employees)
Monrovia, US
Size (employees)
336 (est)
STAAR Surgical was founded in 1982 and is headquartered in Monrovia, US

STAAR Surgical Office Locations

STAAR Surgical has offices in Monrovia, Nidau and Tustin
Monrovia, US (HQ)
1911 Walker Ave
Nidau, CH
104 Hauptstrasse

STAAR Surgical Financials and Metrics

STAAR Surgical Financials

STAAR Surgical's revenue was reported to be $82.4 m in FY, 2016

Revenue (Q2, 2017)

21.9 m

Gross profit (Q2, 2017)

15.5 m

Gross profit margin (Q2, 2017), %


Net income (Q2, 2017)

(971 k)

EBIT (Q2, 2017)

(1.3 m)

Market capitalization (11-Dec-2017)

673.7 m

Cash (30-Jun-2017)

13.4 m


664.7 m
STAAR Surgical's current market capitalization is $673.7 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016


72.2 m75 m77.1 m82.4 m

Revenue growth, %


Cost of goods sold

21.9 m26.2 m24.4 m24.1 m

Gross profit

50.3 m48.8 m52.7 m58.4 m
USDQ3, 2013Q3, 2014Q1, 2015Q2, 2014Q3, 2015Q1, 2015Q2, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017


17.1 m18.2 m20.2 m20 m18.8 m18.9 m18.7 m19.3 m21 m20.1 m20.4 m21.9 m

Cost of goods sold

5 m6.3 m6.3 m6.4 m6 m6 m6.3 m6.3 m6.3 m5.2 m5.8 m6.5 m

Gross profit

12.1 m11.9 m13.9 m13.7 m12.8 m12.9 m12.4 m13 m14.6 m14.9 m14.6 m15.5 m

Gross profit Margin, %

USDFY, 2013FY, 2014FY, 2015FY, 2016


23 m13 m13.4 m14 m

Accounts Receivable

10.7 k11.1 k15.7 k16.3 k


12.5 k15.7 k15.9 k14.8 m

Current Assets

50.1 m44.9 m49.1 m49.9 m
USDQ3, 2013Q3, 2014Q1, 2015Q2, 2014Q3, 2015Q1, 2015Q2, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017


23.4 m18.4 m21.1 m19.2 m16.1 m10.8 m15.3 m9 m12.7 m14.3 m13.5 m13.4 m


11.9 m15.7 m13.8 m14.9 m14.6 m15.3 m14.2 m16 m15.7 m15.9 m14.6 m13.5 m

Current Assets

47.9 m49.4 m51.1 m50.7 m48.1 m43 m46.6 m46.2 m48.9 m49.7 m49 m47.8 m


6.5 m9.3 m8.8 m9.3 m9.9 m9.9 m9.9 m11 m11.4 m11.7 m12.1 m11.6 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

398 k(8.4 m)(6.5 m)(12.1 m)

Depreciation and Amortization

1.7 m2.1 m2.2 m2.7 m

Accounts Receivable

(2.9 m)(934 k)(5 m)(771 k)


(1.6 m)(3.9 m)327 k1.8 m
USDQ3, 2013Q3, 2014Q1, 2015Q2, 2014Q3, 2015Q1, 2015Q2, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

525 k(2.7 m)(1.4 m)(1.8 m)(1.8 m)(2.3 m)(1.6 m)(8 m)(2.1 m)(1.8 m)(2.2 m)

Accounts Payable

6.3 m5.3 m5.8 m4.9 m4.8 m6.9 m8.7 m8 m7.6 m
Y, 2017


-503.6 x

Financial Leverage

1.7 x
Show all financial metrics

STAAR Surgical Operating Metrics

FY, 2016

Patents Issued


Patents Pending



Show all operating metrics

STAAR Surgical Market Value History

STAAR Surgical Revenue Breakdown

STAAR Surgical's Web-traffic and Trends

STAAR Surgical Online and Social Media Presence

STAAR Surgical Company Life and Culture

You may also be interested in